Patents Assigned to SB Corporation
  • Compounds and uses thereof
    Patent number: 7005434
    Abstract: The present invention relates to novel compounds and the treatment of mammalian diseases in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred.
    Type: Grant
    Filed: January 18, 2002
    Date of Patent: February 28, 2006
    Assignee: SB Corporation
    Inventor: Marcus A. Semones